Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus

OBJECTIVES: To assess glucagon-like peptide 1 (GLP-1) secretion after oral glucose tolerance tests (OGTTs) in subjects with newly diagnosed type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), and normal glucose tolerance (NGT) to clarify changes in GLP-1 secretion during the course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao-Li, Ye, Fang, Li, Jun, Zhu, Ling-Yun, Feng, Gang, Chang, Xiang-Yun, Sun, Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724679/
https://www.ncbi.nlm.nih.gov/pubmed/26739974
http://dx.doi.org/10.15537/smj.2016.1.12035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724679/
https://www.ncbi.nlm.nih.gov/pubmed/26739974
http://dx.doi.org/10.15537/smj.2016.1.12035

Ejemplares similares